Bacillus Calmette-Guerin versus epirubicin for primary, secondary or concurrent carcinoma in situ of the bladder: results of a European Organization for the Research and Treatment of Cancer--Genito-Urinary Group Phase III Trial (30906). (Q45219163)
Jump to navigation
Jump to search
scientific article published in February 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bacillus Calmette-Guerin versus epirubicin for primary, secondary or concurrent carcinoma in situ of the bladder: results of a European Organization for the Research and Treatment of Cancer--Genito-Urinary Group Phase III Trial (30906). |
scientific article published in February 2005 |
Statements
1 reference
Bacillus Calmette-Guerin versus epirubicin for primary, secondary or concurrent carcinoma in situ of the bladder: results of a European Organization for the Research and Treatment of Cancer--Genito-Urinary Group Phase III Trial (30906). (English)
1 reference
Theo M de Reijke
1 reference
Richard J Sylvester
1 reference
Karl Heinz Kurth
1 reference
Reg R Hall
1 reference
Maurizio Brausi
1 reference
Kees van de Beek
1 reference
K E J Landsoght
1 reference
Paul Carpentier
1 reference
European Organization for the Research and Treatment of Cancer-Genito-Urinary Group
1 reference
1 February 2005
1 reference
1 reference
173
1 reference
2
1 reference
405-409
1 reference
Identifiers
1 reference
1 reference